Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TAF9 RNA polymerase II, TATA box binding protein-associated factor, 32kDa pseudogene is a non-coding genetic element similar in sequence to the TAF9 gene, which functions as a subunit in the transcription factor IID (TFIID) complex. This pseudogene does not encode a functional protein and is not known to have a direct biological function or role in disease. It is not considered a drug target and is primarily of interest as a genomic element reflecting evolutionary processes or possible non-coding regulatory interactions. For pharmacological and functional purposes, the canonical target is TAF9, not this pseudogene[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TAF9 RNA polymerase II, TATA box binding protein-associated factor, 32kDa pseudogene (TAF9P).